Hai-Bo Wang, Qiu-Hua Mo, and Ze Yang (2015) HIV Vaccine Research: The Challenge and the Way Forward. J Immunol Res. 2015; 2015: 503978. Published online 2015 Mar 15. doi: 10.1155/2015/503978Wang HB, Mo QH, Yang Z. HIV vaccine research: the challenge and the way forward. J ...
HIV vaccine research: the challenge and the way forward. Human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) is a worldwide epidemic, with over 35 million people infected currently. Theref... Hai-Bo,Wang,Qiu-Hua,... - 《Journal of Immunology Research》 被引量: 14发表...
Advance and challenge in human immunodeficiency virus vaccine research and historic opportunity for China 来自 知网 喜欢 0 阅读量: 30 摘要: After having gone through the bumpy road of the failure of first and second generations of human immunodeficiency virus (HIV) vaccines,the first beam just...
infection with human immunodeficiency virus (HIV) continues to cause substantial morbidity and mortality. An estimated 1.5 million people worldwide acquired HIV in 2021 (ref.1). Women are not only biologically more susceptible to HIV-1 infection than men...
Purified rabies vaccine cultured on Vero cells (Verorab, sanofi pasteur) is WHO-approved for pre- and post-exposure prophylaxis by intradermal and intramus... S Toovey - 《Travel Medicine & Infectious Disease》 被引量: 60发表: 2007年 Meeting the Challenge of Vaccine Design To Control HIV and...
Killing Kinetics of Simian Immunodeficiency Virus-Specific We recently showed that the baseline prechallenge levels, and rates of expansion, of recombinant DNA and poxvirus vaccine-induced SIV-specific T cells correlate with control of wild-type virus at an immunodominant Gag epitope ( 21 ). ... ...
were protective against repeated intrarectal challenge with autologous SHIV11. However, inducing such high titers of nAbs that persist for long periods is a demanding task and has not been achieved with HIV Env immunogens. Therefore, vaccination approaches that can lower the threshold of protective ...
94. Willey R, Nason MC, Nishimura Y, Follmann DA, Martin MA: Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay. AIDS Res Hum Retroviruses. 2010; 26(1):89–98. 95. Yang H, Wu H, Hancock G, Clutton ...
Consistent with these results, preclinical studies have demonstrated that rAd5 vectors expressing simian immunodeficiency virus (SIV) Gag failed to reduce peak or setpoint viral loads after SIV challenge of rhesus monkeys (Macaca mulatta) that lacked the protective MHC class I allele Mamu-A*01 (ref...
Heroin challenge of immunized and control mice. The locomotion (a) and distance travelled (b) by mice in 5 min were monitored before and after subcutaneous heroin injection. The red track is the visual tracing of the locomotion of a representative mouse. The distance travelled, which was der...